NCT04263597: An ongoing trial by Children's Hospital Medical Center, Cincinnati
This trial is ongoing. It must report results 5 months, 1 week from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04263597 |
|---|---|
| Title | Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients to Maintain Intestinal Homeostasis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 26, 2020 |
| Completion date | May 23, 2025 |
| Required reporting date | May 23, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |